This morning, Supernus announced it received FDA approval for Oxtellar XR, its extended-release (ER) formulation of the anti-epilepsy drug oxcarbazepine. According to officials at Supernus, they believe the label points to clear differentiation on...
Lundbeck is pleased to report that ONFI™ (clobazam) Tablets CIV is once again available at retail pharmacies in the state of Pennsylvania with a prescription from a healthcare professional. We regret the difficulty some patients faced due...
The New York Times Magazine devoted its cover story to the management of epilepsy with the Ketogenic diet in its Sunday November 21 issue.  To read the full story, please click the link below: Read Here
Click here for part 1: Ramblings from the Bench and Bedside   Let me tell you why you should be very excited about the upcoming annual meeting of the American Epilepsy Society (AES), which will occur in my town (San Antonio, TX) on December...
Welcome to the column.  Every couple of months, I will draw from my experiences as an Epilepsy clinician, scientist or educator, to provide epilepsy.com readers with some thoughts about recent advances on our understanding and treatment of...

Pages